ticagrelor combined with ASA
Showing 1 - 25 of >10,000
Cerebrovascular Accident, Cerebrovascular Accident, Acute Trial in Beijing (ticagrelor + ASA, Placebo+ASA)
Completed
- Cerebrovascular Accident
- Cerebrovascular Accident, Acute
- ticagrelor + ASA
- Placebo+ASA
-
Beijing, ChinaPeking University Third Hospital
Jul 4, 2021
Coronary Artery Disease, Myocardial Infarction Trial in Ottawa (Active Comparator: Dual Antiplatelet Therapy (DAPT) - Aspirin 81
Suspended
- Coronary Artery Disease
- Myocardial Infarction
- Active Comparator: Dual Antiplatelet Therapy (DAPT) - Aspirin 81 mg + Ticagrelor 60mg twice daily
- +2 more
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Feb 17, 2022
Antiplatelet Therapies in Depression and Coronary Disease
Recruiting
- Coronary Artery Disease
- Depression
- standard Aspirin (ASA) + clopidogrel (CLP) therapy
- +2 more
-
Milan, Italy
- +1 more
Apr 6, 2023
Individualized and Combined Effects of Smoking and Diabetes on the Antiplatelet Activity in Patients Undergoing Primary
Recruiting
- Individualized and Combined Effects of Smoking and Diabetes on the Antiplatelet Activity in Patients Undergoing Primary Percutaneous Coronary Intervention
-
Cairo, EgyptFaculty of medicine of girls, Cardiology department, Al-Azhar Un
Jun 10, 2023
Peripheral Artery Disease, Type 2 Diabetes Trial in New York (Aspirin, Ticagrelor, Aspirin Placebo)
Completed
- Peripheral Artery Disease
- Type 2 Diabetes
- Aspirin
- +3 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Mar 18, 2022
Thrombosis Trial in Nanjing (Aspirin?clopidogrel? or SHR2285, Aspirin?ticagrelor? or SHR2285)
Completed
- Thrombosis
- Aspirin、clopidogrel、placebo or SHR2285
- Aspirin、ticagrelor、placebo or SHR2285
-
Nanjing, Jiangsu, ChinaNanjing Drum Tower Hospital
Jun 30, 2022
Exclusive Enteral Nutrition, Ulcerative Colitis, Children Trial (exclusive enteral nutrition, regular food)
Not yet recruiting
- Exclusive Enteral Nutrition
- +2 more
- exclusive enteral nutrition
- regular food
- (no location specified)
Dec 5, 2022
Coronary Artery Disease, Healthy Participants Trial in Edinburgh (Ticagrelor, BMS-986141, Aspirin)
Recruiting
- Coronary Artery Disease
- Healthy Participants
- Ticagrelor
- +2 more
-
Edinburgh, United KingdomLocal Institution - 0001
May 3, 2022
Acute Coronary Syndrome Trial in Worldwide (Ticagrelor 90mg twice daily and ASA 75-100 mg daily, ASA 75-160 mg daily)
Recruiting
- Acute Coronary Syndrome
- Ticagrelor 90mg twice daily and ASA 75-100 mg daily
- ASA 75-160 mg daily
-
Aalborg, Denmark
- +21 more
Apr 6, 2021
Acute Coronary Syndrome Trial in Montreal (Ticagrelor 90mg, Clopidogrel 75mg, acetylsalicylic acid (ASA) 81mg)
Active, not recruiting
- Acute Coronary Syndrome
- Ticagrelor 90mg
- +2 more
-
Montreal, Quebec, CanadaMcGill University Health Centre
Apr 14, 2021
Aortic Valve Stenosis Trial in Athens (Ticagrelor plus ASA, Clopidogrel plus ASA)
Completed
- Aortic Valve Stenosis
- Ticagrelor plus ASA
- Clopidogrel plus ASA
-
Athens, Greece1st Department of Cardiology, Hippokration Hospital
Mar 1, 2021
Facial Rhytides, Skin Folds, Loss of Volume and Skin Quality Trial in Brazil (JUVÉDERM, BOTOX, HArmonyCA Lidocaine)
Not yet recruiting
- Facial Rhytides
- +2 more
- JUVÉDERM
- +2 more
-
Brasilia, Brazil
- +6 more
Jan 25, 2023
Stable Chronic Angina Trial in Shiraz (Clopidogrel, Ticagrelor)
Completed
- Stable Chronic Angina
-
Shiraz, Iran, Islamic Republic ofProfessor Kojuri Cardiology Clinic
May 12, 2023
Stroke, Transient Ischemic Attack Trial in China (Ticagrelor and Aspirin, Clopidogrel and Aspirin)
Recruiting
- Acute Nondisabling Ischemic Stroke
- Transient Ischemic Attack
- Tagrelor combined with aspirin
- Clopidogrel combined with aspirin
-
Beijing, ChinaPeking University Third Hospital
Jun 27, 2021
Myocardial Infarction Trial in Jacksonville (Prasugrel, Vorapaxar, Aspirin)
Completed
- Myocardial Infarction
- Prasugrel
- +3 more
-
Jacksonville, FloridaUniversity of Florida
Sep 15, 2020
Coronary Artery Disease (CAD) Trial in Worldwide (Ticagrelor, Acetylsalicylic Acid, Clopidogrel)
Completed
- Coronary Artery Disease (CAD)
- Ticagrelor
- +2 more
-
Brisbane, Australia
- +129 more
Mar 13, 2022
Stroke, Transient Ischemic Attack Trial in China (Ticagrelor and Aspirin, Clopidogrel and Aspirin)
Completed
- Stroke
- Transient Ischemic Attack
- Ticagrelor and Aspirin
- Clopidogrel and Aspirin
-
Anqing, Anhui, China
- +213 more
Nov 30, 2021
Adverse Reactions of Ticagrelor on Ischemic Cerebrovascular
Not yet recruiting
- Cerebral Infarction
- +3 more
- (no location specified)
Jan 29, 2023
Stroke, Stroke, Ischemic, Atherosclerosis Trial in Paris (Colchicine 0.5 MG, Ticagrelor 90mg, Aspirin 75-300mg)
Not yet recruiting
- Stroke
- +7 more
- Colchicine 0.5 MG
- +2 more
-
Paris, FranceURC Lariboisière-Fernand Widal-Saint Louis
Aug 2, 2022
Platelet Sub-study of the TWILIGHT Trial
Completed
- Coronary Artery Disease
- Myocardial Infarction
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Feb 24, 2020
Acute Myocardial Infarction, Cardiogenic Shock Trial in Czechia, Slovakia (Cangrelor, Ticagrelor)
Recruiting
- Acute Myocardial Infarction
- Cardiogenic Shock
-
Prague, Please Select, Czechia
- +24 more
Oct 3, 2022
Stroke, Transient Ischemic Attack Trial in Beijing (Clopidogrel, Placebo of clopidogrel and Asprin)
Completed
- Stroke
- Transient Ischemic Attack
- Clopidogrel
- Placebo of clopidogrel and Asprin
-
Beijing, ChinaBeijing Tian Tan Hospital, Capital Medical University
Jul 13, 2020
Ulcerative Colitis, Efficacy, Self, Biologics Trial in China (Infliximab, Vedolizumab, Mesalazine)
Not yet recruiting
- Ulcerative Colitis
- +3 more
- Infliximab
- +2 more
-
Chongqing, Chongqing, China
- +10 more
Jan 11, 2022
Acute Ischaemic Stroke, Transient Ischaemic Attack Trial in Worldwide (Ticagrelor, Placebo)
Completed
- Acute Ischaemic Stroke
- Transient Ischaemic Attack
- Ticagrelor
- Placebo
-
Adrogué, Argentina
- +387 more
Dec 21, 2020